Zimmer Biomet Holdings Inc (ZBH)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$100.00

Buy

$114.97

arrow-up$0.56 (+0.55%)

Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris.
Prices updated at 02 May 2025, 23:08 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up1.47%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Christopher B. Begley
CEO
Mr. Ivan Tornos
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
17,000
Head office
345 East Main Street
Warsaw
United States
46580
mobile
+1 574 373-3333
letter
Zach.Weiner@ZimmerBiomet.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Christopher B. Begley
Chairman of the Board
0.24m--0.46m-
Mr. Michael J. Farrell
Independent Director
0.13m--0.35m-
Mr. Ivan Tornos
Director, President and Chief Executive Officer
1.24m--14.99m-
Mr. Arthur J. Higgins
Independent Director
0.11m--0.35m-
Ms. Betsy J. Bernard
Independent Director
0.13m--0.35m-
Mr. Robert A. Hagemann
Independent Director
0.14m--0.37m-
Mr. Chad F. Phipps
Senior Vice President, General Counsel and Secretary
-----
Ms. Maria Teresa Hilado
Independent Director
0.11m--0.32m-
Mr. Suketu Upadhyay
Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain
0.88m--5.88m-
Ms. Rachel Ellingson
Senior Vice President and Chief Administrative Officer
-----
Mr. Sang Yi
Group President, Asia Pacific
0.69m--3.15m-
Ms. Sreelakshmi Kolli
Independent Director
0.13m--0.40m-
Mr. Paul Stellato
Vice President, Controller and Chief Accounting Officer
-----
Mr. Syed A. Jafry
Independent Director
0.11m--0.38m-
Ms. Lori Winkler
Senior Vice President and Chief Human Resources Officer
-----
Mr. Wilfred van Zuilen
Group President, Europe, Middle East and Africa
0.67m--3.48m-
Mr. Devdatt Kurdikar, PhD
Independent Director
0.08m--0.12m-
Mr. Mark Bezjak
President, Americas
0.64m--3.05m-
Mr. Louis A. Shapiro
Independent Director
0.11m--0.37m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc22,886,1620.04211-398676-1.7121730 Apr 202511.57
Dodge & Cox19,118,4361.17521204464511.97534330 Apr 20259.66
BlackRock Inc16,131,8340.03448-562906-3.37175730 Apr 20258.15
T. Rowe Price Associates, Inc.14,760,4440.179741763371.20910430 Apr 20257.46
T Rowe Price Associates, Inc14,616,453-518958755.05103230 Apr 20257.34

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Mr. Arthur J. Higgins--33,697--
31 Dec 2024-Mr. Christopher B. Begley--21,359--
31 Dec 2024-Mr. Robert A. Hagemann--29,235--
31 Dec 2024-Ms. Maria Teresa Hilado--9,039--
31 Dec 2024-Mr. Michael J. Farrell--15,259--
31 Dec 2024-Ms. Sreelakshmi Kolli--4,082--
31 Dec 2024-Mr. Syed A. Jafry--6,137--
31 Dec 2024-Mr. Devdatt Kurdikar, PhD--385--
31 Dec 2024-Mr. Louis A. Shapiro--1,108--
10 Nov 2024-Mr. Suketu Upadhyay108.48769,88329,745--
10 Nov 2024-Mr. Suketu Upadhyay-----
08 Nov 2024-Mr. Suketu Upadhyay--15,948--
10 Nov 2024-Mr. Suketu Upadhyay--36,842--
30 Sep 2024-Mr. Arthur J. Higgins--33,363--
30 Sep 2024-Mr. Christopher B. Begley--20,745--
30 Sep 2024-Mr. Robert A. Hagemann--28,851--
30 Sep 2024-Ms. Maria Teresa Hilado--8,760--
30 Sep 2024-Mr. Michael J. Farrell--14,919--
30 Sep 2024-Ms. Sreelakshmi Kolli--3,925--
30 Sep 2024-Mr. Syed A. Jafry--5,994--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.